BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3975177)

  • 1. Amifloxacin distribution in the dog prostate.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Prostate; 1985; 6(2):163-8. PubMed ID: 3975177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of ciprofloxacin in the dog prostate and various tissues.
    Frimodt-Møller PC; Dørflinger T; Madsen PO
    Urol Res; 1984; 12(6):283-6. PubMed ID: 6240821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of quinoline carboxylic acid derivatives in the dog prostate.
    Jensen KM; Madsen PO
    Prostate; 1983; 4(4):407-14. PubMed ID: 6223287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and disposition of amifloxacin in laboratory animals.
    Johnson JA; Benziger DP
    Antimicrob Agents Chemother; 1985 May; 27(5):774-81. PubMed ID: 4015071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial substances in secretion, interstitial fluid, and tissue of normal and infected canine prostate glands.
    Baumueller A; Madsen PO
    Urol Res; 1982 Feb; 10(1):31-5. PubMed ID: 7200274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
    Baltch AL; Sutphen NT; Smith RP; Conley PE
    Clin Ther; 1984; 7(1):73-80. PubMed ID: 6440708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fleroxacin (Ro 23-6240) distribution in canine prostatic tissue and fluids.
    Gasser TC; Graversen PH; Madsen PO
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1010-3. PubMed ID: 3116916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
    Neu HC; Labthavikul P
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolone penetration into canine vaginal and urethral secretions.
    Gasser TC; Graversen PH; Larsen EH; Dørflinger T
    Scand J Urol Nephrol Suppl; 1987; 104():101-5. PubMed ID: 3481457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
    Dorfman M; Barsanti J; Budsberg SC
    Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
    Cook JA; Silverman MH; Schelling DJ; Nix DE; Schentag JJ; Brown RR; Stroshane RM
    Antimicrob Agents Chemother; 1990 Jun; 34(6):974-9. PubMed ID: 2393295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys.
    McCoy LF; Crawmer BP; Benziger DP
    Antimicrob Agents Chemother; 1985 May; 27(5):769-73. PubMed ID: 4015070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
    Appelbaum PC; Spangler SK; Sollenberger L
    J Antimicrob Chemother; 1986 Dec; 18(6):675-9. PubMed ID: 3469178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prostatic tissue concentrations of rosoxacin.
    Jensen KM; Patel RB; Welling PG; Madsen PO
    Prostate; 1982; 3(5):523-9. PubMed ID: 7145776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Freeman S; Wormuth J; Cornett J
    Eur J Clin Microbiol; 1985 Oct; 4(5):515-6. PubMed ID: 4065142
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
    Stroshane RM; Silverman MH; Sauerschell R; Brown RR; Boddy AW; Cook JA
    Antimicrob Agents Chemother; 1990 May; 34(5):751-4. PubMed ID: 2360815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin distribution in prostatic tissue and fluid following oral administration.
    Boerema JB; Dalhoff A; Debruyne FM
    Chemotherapy; 1985; 31(1):13-8. PubMed ID: 3156024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.
    Maigaard S; Frimodt-Möller N; Hoyme U; Madsen PO
    Invest Urol; 1979 Sep; 17(2):149-52. PubMed ID: 468515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversed-phase ion-pair high-performance liquid chromatographic determination of fluoroquinolones in human plasma.
    Nangia A; Lam F; Hung CT
    J Pharm Sci; 1990 Nov; 79(11):988-91. PubMed ID: 2292775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.